SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 1,616.65 |
| Enterprise Value ($M) | 2,480.61 |
| Book Value ($M) | -744.16 |
| Book Value / Share | -1.07 |
| Price / Book | -2.17 |
| NCAV ($M) | -945.58 |
| NCAV / Share | -1.36 |
| Price / NCAV | -1.71 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -2.14 |
| Return on Assets (ROA) | -1.17 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.64 |
| Current Ratio | 2.68 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 163.15 |
| Assets | 364.57 |
| Liabilities | 1,108.73 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Cambridge Equities, LP | 83.50 | 7.07 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,025,522 | 3,793,290 | 27.04 | |
| 2,428,528 | 5,697,527 | 42.62 | |
| 1,319,670 | 4,650,281 | 28.38 | |
| 2,395,860 | 5,815,539 | 41.20 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| HLVX – HilleVax, Inc. | HOWL – Werewolf Therapeutics, Inc. |
| HUMA – Humacyte, Inc. | IDXX – IDEXX Laboratories, Inc. |
| IDYA – IDEAYA Biosciences, Inc. |
Financial data and stock pages provided by
Fintel.io